Bharat Rasayan Ltd. (NSE: BHARATRAS) Ltd. : Q3 FY23 Results Out; Total Income fell 7% YoY

Bharat Rasayan Ltd (NSE:BHARATRAS) is an India-based company engaged in the manufacture and marketing of agrochemicals and pharmaceutical intermediates. The company produces a range of insecticides, fungicides, herbicides, and other crop protection products. It also produces intermediates for use in the pharmaceutical industry. The company exports its products to various countries in Asia, Europe, and the Americas.

The company reported a total income of Rs. 315.25 crores during the period ended December 31, 2022, which is an increase from the previous quarter’s income of Rs. 296.20 crore. However, the company’s net profit for the period ended December 31, 2022, was Rs. 33.77 crore, a slight increase from the net profit of Rs. 22.93 crore reported for the previous quarter. The EPS for the period ended December 31, 2022, was Rs. 81.27, which is an improvement from the EPS of Rs. 55.18 reported for the previous quarter.

Comparing the period ended December 31, 2022, to the same period last year, the company’s total income decreased from Rs. 338.11 crore to Rs. 315.25 crore. The net profit also decreased from Rs. 45.88 crore to Rs. 33.77 crore, and the EPS decreased from Rs. 110.42 to Rs. 81.27.

For the nine-month period ended December 31, 2022, the company reported a total income of Rs. 946.86 crore, which is an increase from the same period last year, where the total income was Rs. 864.88 crore. The net profit for the nine-month period ended December 31, 2022, was Rs. 94.36 crore, a decrease from the Rs. 111.43 crore reported for the same period last year. The EPS for the nine-month period ended December 31, 2022, was Rs. 227.09, a decrease from the EPS of Rs. 268.17 reported for the same period last year.

Overall, Bharat Rasayan Ltd has reported a slight improvement in its net profit and EPS for the period ended December 31, 2022, compared to the previous quarter. However, there has been a decrease in total income, net profit, and EPS when compared to the same period last year.